| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2000 | CN1275983A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
| 12/06/2000 | CN1275982A Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 12/06/2000 | CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors |
| 12/06/2000 | CN1275979A Isoquinolines as urokinase inhibitors |
| 12/06/2000 | CN1275978A Metalloproteinase inhibitors |
| 12/06/2000 | CN1275977A Heterocyclic thioesters and ketones |
| 12/06/2000 | CN1275913A Intra-cancer-cell nuclease activator |
| 12/06/2000 | CN1275912A Novel amide derivatives |
| 12/06/2000 | CN1275911A Method of preventing or treating estrogen-dependent diseases and disorders |
| 12/06/2000 | CN1275910A Therapeutic agents |
| 12/06/2000 | CN1275909A In-modulators |
| 12/06/2000 | CN1275900A Cosmetic formulations for the prevention and therapy or hair loss |
| 12/06/2000 | CN1275886A Method for lowering platelet counts |
| 12/06/2000 | CN1275623A Oligo-Amorphophallus rivieri glucomannan glycan aldehydic acid propyl ester sodium sulfovindte and preparation and use thereof |
| 12/06/2000 | CN1275565A Menispermum dauricum extract, its extractive process and application |
| 12/06/2000 | CN1275564A Quinoline ketone derivant and antianaphylaction using same as active substance |
| 12/06/2000 | CN1275388A Traditional Chinese medicine composition for treating ischemic encephalopathy and preparation process thereof |
| 12/06/2000 | CN1275385A Medicinal composition for treating beriberi and preparation process thereof |
| 12/06/2000 | CN1275382A Ointment for treating hemorrhoid complicated by anal fistula and its preparation method |
| 12/06/2000 | CN1275378A Medicinal bait of bolbstemmatoside B for preventing and controlling haman and animal viral disease |
| 12/06/2000 | CN1275377A Anticancer medicine composition |
| 12/06/2000 | CN1275376A Hydroxy diphenyl ether compound |
| 12/06/2000 | CN1275375A Process for preparation of spraying granule of ovoflavin |
| 12/06/2000 | CN1275331A Higher unsaturated fatty acid composition |
| 12/06/2000 | CN1059213C Preparation of d4T from 5-methyluridine |
| 12/06/2000 | CN1059212C 9-N-ethenyl derivatives of 9 (S)-erythromycylamine |
| 12/06/2000 | CN1059210C Process for preparation of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrbenz [cd] indoles and acid additive salt used as medicine |
| 12/06/2000 | CN1059110C Medicine for treating psychosis and nerve system disease |
| 12/06/2000 | CN1059088C Powder preparation for healing damaged skin |
| 12/06/2000 | CN1059087C Method for producing bait with anti prawn disease function |
| 12/06/2000 | CN1059086C Anti-beta-lactamase antibiotic composition |
| 12/05/2000 | US6156907 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 12/05/2000 | US6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 12/05/2000 | US6156901 Spiro[cyclopent[b]indole-piperidines] |
| 12/05/2000 | US6156899 N-aryl-2-hydroxyalkylamido compositions for inducing/stimulating hair growth and/or retarding hair loss and/or for treating hyperseborrhea and/or acne |
| 12/05/2000 | US6156894 Process for manufacturing α.sub. 1L-adrenoceptor antagonists |
| 12/05/2000 | US6156802 Cholesterol-lowering composition |
| 12/05/2000 | US6156800 Drugs for cardiovascular disorders and hypotensive agents |
| 12/05/2000 | US6156799 Method of increasing bone volume using non-naturally-occurring FP selective agonists |
| 12/05/2000 | US6156798 Cardiovascular disorders, nervous system disorders, antiarthritic disorders and enzyme inhibitors |
| 12/05/2000 | US6156794 Nervous system disorders or alzheimers disease |
| 12/05/2000 | US6156793 Prophylactic/therapeutic agents for atherosclerosis |
| 12/05/2000 | US6156792 Calcium mupirocin non-aqueous nasal spray for otitis media or for recurrent acute bacterial sinusitis |
| 12/05/2000 | US6156791 Methods for treatment using procyanidin topoisomerase inhibitors |
| 12/05/2000 | US6156789 Brain disorders and anticarcinogenic agents |
| 12/05/2000 | US6156788 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/05/2000 | US6156786 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome |
| 12/05/2000 | US6156785 Method for increasing oxygen tension in the optic nerve and retina |
| 12/05/2000 | US6156784 Ester, acid or derivatives of amides, sulfonamides or thioamides |
| 12/05/2000 | US6156783 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
| 12/05/2000 | US6156781 Antiinflammatory agents for skin |
| 12/05/2000 | US6156780 Treatment of fecal incontinence |
| 12/05/2000 | US6156779 Fungicides against candida |
| 12/05/2000 | US6156777 Use of pramipexole as a neuroprotective agent |
| 12/05/2000 | US6156775 Use of fluorinated triazoles in treating affective and attention disorders |
| 12/05/2000 | US6156774 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors |
| 12/05/2000 | US6156773 Pharmaceutical composition |
| 12/05/2000 | US6156771 Method for alleviation of lower gastrointestinal disorders in a human patient |
| 12/05/2000 | US6156770 Antiviral agents, bactericides, antitumor agents and antihistamines |
| 12/05/2000 | US6156769 Antipruitus drugs for mammals |
| 12/05/2000 | US6156768 Alpha- and beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 12/05/2000 | US6156765 Method of treating and preventing vasospasm |
| 12/05/2000 | US6156764 Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type |
| 12/05/2000 | US6156759 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and method for use thereof |
| 12/05/2000 | US6156757 1,2,3,4-tetrahydro-benzofuro[3,2-C]pyridine derivatives |
| 12/05/2000 | US6156756 Anticoagulants |
| 12/05/2000 | US6156755 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures |
| 12/05/2000 | US6156753 Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 12/05/2000 | US6156752 Optically active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 12/05/2000 | US6156750 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/05/2000 | US6156749 Use of NK-1 receptor antagonists for treating movement disorders |
| 12/05/2000 | US6156747 Psychological, gastrointestinal, cardiovascular disorders |
| 12/05/2000 | US6156745 2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors |
| 12/05/2000 | US6156743 Method of decreasing fatigue |
| 12/05/2000 | US6156742 Emergency contraceptive kit |
| 12/05/2000 | US6156741 Nervous system disorders |
| 12/05/2000 | US6156739 Quinazolinone compounds |
| 12/05/2000 | US6156738 Controlling nighttime blood sugar level |
| 12/05/2000 | US6156737 Therapy for hepatitis b |
| 12/05/2000 | US6156736 Gene transcription and ionizing radiation: methods and compositions |
| 12/05/2000 | US6156735 Arginine silicate inositol complex and use thereof |
| 12/05/2000 | US6156723 Genistein, staurosporine, 6-thiguanine and 2-aminopurine |
| 12/05/2000 | US6156700 Herbicides |
| 12/05/2000 | US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders |
| 12/05/2000 | US6156541 Compositions and methods for catalyzing hydrolysis of HIV gp120 |
| 12/05/2000 | US6156537 Phospho-N-acetylmuramoyl-pentapeptide transferase of Streptococcus pneumoniae |
| 12/05/2000 | US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect |
| 12/05/2000 | US6156534 Producing antibiotic cefprozil, cefadroxil or amoxicillin by reacting penicillin or cephalosporin derivitive with 4-hydroxy-d-phenylglycyl ester in presence of penicillin g amidase |
| 12/05/2000 | US6156525 Method for judging eradication of H. pylori based on rates of changes in the pepsinogen I/II ratio |
| 12/05/2000 | US6156347 Controlled release chromium picolinate |
| 12/05/2000 | US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 12/05/2000 | US6156342 Controlled release oral dosage form |
| 12/05/2000 | US6156341 Stability; oxidation resistance |
| 12/05/2000 | US6156339 Forming solution or suspension in solvent of water soluble or water dispersible carrier, filler and pharmaceutically active substance with unacceptable taste in association with lipid; forming discrete units; removing solvent to form unit dosage |
| 12/05/2000 | US6156335 Tolerated, stable, effective, prevents the crystallisation of active ingredient in the matrix, ensures adequate and extended levels of the active ingredient in blood, and has tack and adhesive properties |
| 12/05/2000 | US6156312 Administering calcium antagonist and drug that reduces ratio of adenosine phosphate to guanosine phosphate |
| 12/05/2000 | US6156302 Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
| 12/05/2000 | US6156299 Homogeneous mixture of acetylsalicylic acid and solvent |
| 12/05/2000 | US6156294 Composition and method for treatment of otitis media |
| 12/05/2000 | US6156293 Moistening preparation |